Organovo Holdings Inc  

(Public, NYSEMKT:ONVO)   Watch this stock  
Find more results for PINK:ONVO
+0.32 (4.68%)
Dec 26 - Close
NYSEMKT real-time data - Disclaimer
Currency in USD
Range 6.80 - 7.20
52 week 5.12 - 12.38
Open 6.83
Vol / Avg. 783,406.00/1.32M
Mkt cap 576.41M
P/E     -
Div/yield     -
EPS -0.35
Shares 80.40M
Beta     -
Inst. own 20%

Key stats and ratios

Q3 (Sep '14) 2014
Net profit margin -17716.00% -6820.05%
Operating margin -17912.00% -5448.28%
EBITD margin - -5345.78%
Return on average assets -68.69% -76.52%
Return on average equity -73.07% -90.29%
Employees 48 -
CDP Score - -


Suite 150, 5871 Oberlin Drive
San Diego, CA 92121
United States - Map
+1-858-5509993 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Organovo Holdings, Inc. (Organovo), formerly Real Estate Restoration & Rental, Inc., is a development-stage company. The Company has developed and is commercializing a platform technology for the generation of three-dimensional (3D) human tissues that can be employed in drug discovery and development, biological research, and as therapeutic implants for the treatment of damaged or degenerating tissues and organs. On December 28, 2011, Real Estate Restoration and Rental, Inc.�s (RERR) entered into an Agreement and Plan of Merger, pursuant to which RERR merged with its, wholly owned subsidiary, Organovo (Merger Sub). On February 8, 2012, the Company merged with and into Organovo Acquisition Corp. (Acquisition Corp.), a wholly owned subsidiary of Organovo, with the Company surviving the merger as a wholly owned subsidiary of Organovo Holdings (the Merger). As a result of the Merger, Organovo acquired the business of Organovo, Inc.

Officers and directors

Keith Murphy Chairman of the Board, President, Chief Executive Officer
Age: 41
Bio & Compensation  - Reuters
Barry D. Michaels Chief Financial Officer, Corporate Secretary
Age: 63
Bio & Compensation  - Reuters
Sharon Collins Presnell Ph.D. Executive Vice President - Research and Development, Chief Technology Officer
Age: 44
Bio & Compensation  - Reuters
Michael Renard Executive Vice President - Commercial Operations
Age: 54
Bio & Compensation  - Reuters
Eric Michael David Ph.D. Chief Strategy Officer
Age: 41
Bio & Compensation  - Reuters
Richard Heyman Ph.D. Director
Bio & Compensation  - Reuters
Robert F. Baltera Jr. Independent Director
Age: 48
Bio & Compensation  - Reuters
James T. Glover Independent Director
Age: 64
Bio & Compensation  - Reuters
Tamar D. Howson Independent Director
Age: 65
Bio & Compensation  - Reuters